Coronado Biosciences, Inc., a biopharmaceutical company, develops novel immunotherapy agents for the treatment of autoimmune diseases and cancer. Its principal pharmaceutical product candidates in clinical development include Trichuris suis ova or...
http://www.priceseries.com/trade/FBIO-Fortress-Biotech-Inc-stock-gains-35-percent-a-Trade-Record-by-priceSeries-2018022120180323.html
Subscribe by Email
Follow Updates Articles from This Blog via Email
No Comments